Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Apotex, Galderma, Intent, Kowa, Nicox, Orca, Penumbra, Scibase, Serenity, Siemens, Skylinedx.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Arcutis, Aurenar, Biomerieux, Cogent, Envoy, Hengrui, Monopar, Novaliq, Novocure, Praxis, Roche, Saluda, Sarepta, Starmed, Unicycive.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Astrazeneca, Bavarian, Biodexa, Cansino, Capricor, Daiichi, Eisai, Lantheus, Larimar, Nuvation, Satellos, Senzime, SOBI, United, Viridian, Zambon.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Biokin, Carsgen, China Medical System, Daiichi Sankyo, Everest Medicines, Incyte Biosciences Japan, Merz, Natera, Novo Nordisk, Reprocell, Sanofi, Sumitomo, Systimmune, Teijin, Valgen Medtech.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Acadia, Amgen, Arbor, Astrazeneca, Daiichi, Eli Lilly, Everest, Incyte, Johnson, Maat, Omeros, Pharmaessentia, Replimune, Xspray.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aidoc, Celecor, Cercare, Deephealth, Gilead, Ionis, Merck, Pfizer, Radnet, Reprocell, Spectral, Sunshine.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Brightheart, Hepquant, Life, Merck, Natera, Valgen.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Arrowhead, Biokin, Calico, China Medical System, Diasorin, Draeger, ECM, Gilead, Lem, Orion, Portal, Quoin, Sanofi, Spotlight, Systimmune, US Worldmeds.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Achieve, Carsgen, Exeltis USA, Incyte, Masimo, Merz, Moderna, Novo Nordisk, Praxis, Regeneron, Sanofi, Sumitomo, Teijin, Tetmedical, Teva, Viiv.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Iaso, Qihan, Zai Lab.